Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Fenoterol hydrobromide
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Berodual N inhaler
0301040M0BCABAD
|
Berodual | Fenoterol hydrobromide | Respiratory System | No data available |
|
Berotec 200micrograms/dose inhaler
0301011F0BBACAA
|
Berotec | Fenoterol hydrobromide | Respiratory System | No data available |
|
Duovent Autohaler
0301040M0BBACAC
|
Duovent | Fenoterol hydrobromide | Respiratory System | No data available |
|
Duovent inhaler
0301040M0BBAAAA
|
Duovent | Fenoterol hydrobromide | Respiratory System | No data available |
|
Duovent UDVs nebuliser liquid 4ml
0301040M0BBABAB
|
Duovent | Fenoterol hydrobromide | Respiratory System | No data available |
|
Fenoterol 1.25mg/Ipratropium 500microg/4ml neb liq ud vials
0301040M0AAABAB
|
Fenoterol hydrobromide/ipratropium | Fenoterol hydrobromide | Respiratory System | No data available |
|
Fenoterol 100microg/dose / Ipratropium 40microg/dose inh
0301040M0AAAAAA
|
Fenoterol hydrobromide/ipratropium | Fenoterol hydrobromide | Respiratory System | No data available |
|
Fenoterol 100microg/Ipratropium bromide 40microg/dose BA inh
0301040M0AAACAC
|
Fenoterol hydrobromide/ipratropium | Fenoterol hydrobromide | Respiratory System | No data available |
|
Fenoterol 200micrograms/dose inhaler
0301011F0AAAAAA
|
Fenoterol hydrobromide | Fenoterol hydrobromide | Respiratory System | No data available |
|
Fenoterol 50microg/Ipratropium brom 20microg/dose CFC free
0301040M0AAADAD
|
Fenoterol hydrobromide/ipratropium | Fenoterol hydrobromide | Respiratory System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.